Samuel D. Saibil

Toronto, ON M5S1A8, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

CD28-driven ex vivo generation of stem-like memory CD8+ T cells bypassing CD3/TCR signaling.

CD28-driven ex vivo generation of stem-like memory CD8+ T cells bypassing CD3/TCR signaling.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 21, 2026

Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid Tumors.

Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid Tumors.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 05, 2026

Autologous T-cell antigen coupler targeting HER2 (TAC01-HER2) in advanced or metastatic solid tumors.

Autologous T-cell antigen coupler targeting HER2 (TAC01-HER2) in advanced or metastatic solid tumors.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 05, 2026

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.

Journal: Frontiers in oncology

Published: March 27, 2026

Impact of immune checkpoint inhibitors on pregnancy: current evidence and future directions.

Impact of immune checkpoint inhibitors on pregnancy: current evidence and future directions.

Journal: BMJ oncology

Published: March 21, 2026

An Audit of Accessibility and Actionability of Molecular Profiling for Patients with Cancer of Unknown Primary at a Tertiary Care Centre.

An Audit of Accessibility and Actionability of Molecular Profiling for Patients with Cancer of Unknown Primary at a Tertiary Care Centre.

Journal: Clinics and practice

Published: December 23, 2025

Commentary: Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis.

Commentary: Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis.

Journal: Frontiers in oncology

Published: December 14, 2025

Temozolomide reconsidered: Real-World evidence in resistant melanoma cases.

Temozolomide reconsidered: Real-World evidence in resistant melanoma cases.

Journal: The oncologist

Published: November 13, 2025

Beyond the Hazard Ratio: Rethinking Survival Reporting in Cardio-Oncology With Restricted Mean Survival Time.

Beyond the Hazard Ratio: Rethinking Survival Reporting in Cardio-Oncology With Restricted Mean Survival Time.

Journal: JACC. CardioOncology

Published: October 22, 2025

Discordance between biochemical and histological severity in persistent immune checkpoint inhibitor induced liver injury.

Discordance between biochemical and histological severity in persistent immune checkpoint inhibitor induced liver injury.

Journal: BMJ case reports

Published: August 19, 2025

Author Correction: LARP4-mediated hypertranslation drives T cell dysfunction in tumors.

Author Correction: LARP4-mediated hypertranslation drives T cell dysfunction in tumors.

Journal: Nature immunology

Published: August 04, 2025

Protocol for halofuginone-mediated metabolic reprogramming of murine T cells via activation of the GCN2 pathway.

Protocol for halofuginone-mediated metabolic reprogramming of murine T cells via activation of the GCN2 pathway.

Journal: STAR protocols

Published: July 24, 2025

Showing 1-12 of 49

Last Updated: 09/26/2026